Table 3.

Multivariate analyses of OS and DFS in ESCC patients.

	OS				DFS
Multivariate analysis	HR	95%CI	P		HR	95%CI	P
TNM stage (III/II)	1.667	1.005–2.767	0.048*	TNM stage (III/II)	1.68	1.006–2.806	0.047*
N stage (2/1,0)	0.451	0.836–1.496	0.451	N stage (2/1,0)	1.105	0.824–1.481	0.506
FGFR1 (High/Low)	1.502	1.005–2.246	0.045*	Radiotherapy	0.614	0.413–0.913	0.016*

Statistical analysis was evaluated by a proportional hazard model (Cox).

^*P < 0.05. OS overall survival; DFS disease free survival; FGFR1 fibroblast growth factor receptor 1